|
27 Oct 2008 |
Nanoemulsion-Based Intranasal Influenza Vaccine Adjuvant Triggers Robust Immunity Using Significantly Less Antigen
|
|
24 Oct 2008 |
Vaxart Demonstrates Efficacy of Oral Avian Flu Vaccine in Preclinical Studies
|
|
23 Oct 2008 |
GlaxoSmithKline and AFFiRiS sign an exclusive licence and option agreement for therapeutic Alzheimer’s disease candidate vaccines
|
|
17 Oct 2008 |
Aeras and Crucell Announce TB Vaccine Clinical Trial in Kenya; Promising Vaccine Candidate Advances to Phase II Safety Study in South Africa
|
|
16 Oct 2008 |
Cell Genesys Announces Termination of VITAL-1 Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer Based on Outcome of Futility Analysis and Reports Preliminary Analysis of VITAL-2 Trial Results
|
|
15 Oct 2008 |
Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial with Intravenous Delivery of JX-594 Oncolytic Virus
|
|
10 Oct 2008 |
Cyto Pulse, the Karolinska Institute and Uppsala University Hospital Receive Approval from the Swedish Medical Products Agency to Start a Clinical Trial Using a Xenogenic PSA DNA Vaccine
|
|
08 Oct 2008 |
Nventa Presents Findings on Proprietary Toll-Like Receptor 3 (TLR3) Agonist, Poly.ICR, at World Vaccine Congress
|
|
07 Oct 2008 |
Vical and AnGes MG Sign Letter of Intent for Pandemic Influenza Program
|
|
07 Oct 2008 |
Biovest Announces BiovaxID(R) Anti-Cancer Vaccine Prolongs Cancer-Free Survival by 44%
|
|
07 Oct 2008 |
Bavarian Nordic announces positive mature Phase II results from newly acquired prostate cancer vaccine
|
|
07 Oct 2008 |
Oxford Biomedica Announces FDA Agreement on Revisions for Ongoing Trovax Phase III Trist Study
|
|
02 Oct 2008 |
Circassia Initiates Further Phase II Clinical Study Of ToleroMune(R) Anti-Allergy Technology
|
|
01 Oct 2008 |
Apthera Announces Optimal Dose and Schedule of NeuVax for Phase III Clinical Trial in Breast Cancer
|
|
30 Sep 2008 |
VaxInnate's Second Flu Vaccine Candidate Enters Clinical Development; Results Expected in Early 2009
|
|
29 Sep 2008 |
MedImmune Licenses Reverse Genetics Technology to Japan's BIKEN for Use in Influenza Vaccine Development and Production
|
|
25 Sep 2008 |
Successful Results for Mymetics Corporation's Mucosal HIV/AIDS Vaccine Viral Challenge Significantly Exceed Expectations
|
|
23 Sep 2008 |
Pivotal Phase III Pollinex(R) Quattro Ragweed study meets primary efficacy endpoint
|
|
23 Sep 2008 |
Major Adult Vaccine Clinical Trial for Pneumonia Prevention Begins
|
|
22 Sep 2008 |
Opexa Announces Top-Line Results from Phase IIb Clinical Trial of Tovaxin(R) for the Treatment of Multiple Sclerosis
|
|
21 Sep 2008 |
Transgene's Therapeutic Vaccine TG4010: Promising Additional Clinical Data in Non Small Cell Lung Cancer Phase IIb Trial
|
|
21 Sep 2008 |
iBioPharma, Inc. Selects Influenza Vaccine as Its First Clinical Candidate
|
|
21 Sep 2008 |
Novartis MF59(R)-adjuvanted vaccine rapidly induces protective antibody levels against diverse strains of avian flu
|
|
21 Sep 2008 |
Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial
|
|
18 Sep 2008 |
Multi-Pronged Therapeutic Cancer Vaccine Regimen to be Studied in Melanoma Patients
|
